K1 expression immortalizes primary endothelial cells, transforms rodent fibroblasts, and K1 transgenic mice develop spindle cell sarcomatoid tumors and plasmablastic lymphoma, suggesting that the K1 protein is important for KSHV-induced tumor development [15–17]. The gene discussed is KRT1; the disease is neoplasm.